Dr. Alberto L. Rosa holds a Bachelor's degree in Sciences (1983), an MD (1995), a PhD in Chemical Sciences (1987), and a PhD in Clinical Medicine (2002), all from the Universidad Nacional de Córdoba (Argentina). He trained as a geneticist and molecular biologist at CIQUIBIC and INGEBI (Argentina; 1985–1993), and as a medical geneticist at Hôpital Necker-Enfants Malades (France; 1996–1998). He was an International Investigator of the Howard Hughes Medical Institute (USA-Argentina; 1998–2002), Principal Investigator at CIQUIBIC and INIMEC (CONICET; 1991–2002), and Chairman of the Department of Medical Genetics at Sanatorio Allende (Cordoba, Argentina; 2005–2015). Since 1998, he has held honorary positions abroad: Visiting Professor at the University of Paris-Sud and Sabbatical Fellow of INSERM (Paris, France, 1998), Associate Professor in the Department of Neurology at Baylor College of Medicine (Houston, USA; 2000-2001), Research Professor at Washington State University, and Co-Director of the Molecular Laboratory at Sacred Heart Medical Center (Spokane, USA, 2003–2005). He has also served as Medical Advisor for the Telethon Neurorehabilitation Centers in Chile, Uruguay, and Paraguay (2010–2014). More recently, he performed short research stays as an Invited Scientist at the Center for Gene Therapy of Nationwide Children’s Hospital (USA; 2023 and 2024). Dr. Rosa has authored 70 peer-reviewed publications (Scopus h-index: 22). In a seminal contribution, he proposed that DUX4 is a toxic protein underlying the pathogenesis of facioscapulohumeral muscular dystrophy (FSHD). Currently, he is Principal Investigator at the National Research Council of Argentina, Director of the Laboratory of Genetics & Molecular Biology at the Department of Pharmacology, Universidad Nacional de Córdoba, and a Clinical Neurogeneticist and Clinical Genetic Diagnostic Consultant at Sanatorio Allende (Córdoba, Argentina). His current research focuses on the molecular bases of inherited neurological disorders.